Transcode Therapeutics (RNAZ) EBITDA (2021 - 2026)
Transcode Therapeutics (RNAZ) posted EBITDA of -$6.77 million for Q2 2026, compared with -$4.21 million a year earlier.
Powered by 
Analysis
Transcode Therapeutics (RNAZ) EBITDA (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Transcode Therapeutics was -$45.1 million; for FY2025, it came in at -$27.97 million.
- In prior years, Transcode Therapeutics' EBITDA was -$15.57 million in FY2024, -$19.3 million in FY2023, -$18.54 million in FY2022 and -$6.11 million in FY2021.
- Quarterly EBITDA has run from a low of -$17.73 million in Q1 2026 to a high of -$2.15 million in Q3 2024 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$17.73 million (Q1 2026), -$16.04 million (Q4 2025) and -$4.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Transcode Therapeutics | 1.63 Mn | -40.26 Mn | - | -6.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.77 Mn |
| Mar 31, 2026 | -17.73 Mn |
| Dec 31, 2025 | -16.04 Mn |
| Sep 30, 2025 | -4.56 Mn |
| Jun 30, 2025 | -4.21 Mn |
| Mar 31, 2025 | -3.16 Mn |
| Dec 31, 2024 | -5.08 Mn |
| Sep 30, 2024 | -2.15 Mn |
| Jun 30, 2024 | -5.08 Mn |
| Mar 31, 2024 | -3.26 Mn |
| Dec 31, 2023 | -4.07 Mn |
| Sep 30, 2023 | -5.28 Mn |
| Jun 30, 2023 | -5.09 Mn |
| Mar 31, 2023 | -4.86 Mn |
| Dec 31, 2022 | -5.47 Mn |
| Sep 30, 2022 | -4.93 Mn |
| Jun 30, 2022 | -4.68 Mn |
| Mar 31, 2022 | -3.46 Mn |
| Dec 31, 2021 | -2.96 Mn |
| Sep 30, 2021 | -2.35 Mn |
API Access
Transcode Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RNAZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RNAZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RNAZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();